## Background: Multiple lymphomatous polyposis (mlp) results from gastrointestinal involvement by a b-cell lymphoma that originates from the mantle zone of lymphoid follicles. this well described clinicopathologic entity has a poor prognosis: the rate of complete response after conventional chemoth
Primary AL amyloid polyneuropathy successfully treated with high-dose melphalan followed by autologous stem cell transplantation
✍ Scribed by Nagaaki Katoh; Masayuki Matsuda; Takuhiro Yoshida; Masahide Yazaki; Hiroshi Morita; Kazuo Sakashita; Shu-Ichi Ikeda
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 173 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We report 2 patients with polyneuropathy associated with amyloid derived from light chains (AL) who were treated successfully with high‐dose melphalan followed by autologous peripheral blood stem cell transplantation (HDM/SCT). Neuropathic symptoms improved in conjunction with normalization of serum‐free light chains. In addition to amyloid deposits in tissues, an amyloidogenic light chain itself produced by abnormal plasma cells might be harmful to peripheral nerve function, and thus HDM/SCT seems to be a promising therapy for primary AL amyloid polyneuropathy. Muscle Nerve, 2010
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high‐dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre
## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel